Mesenchymal Stem Cells (MSCs) Attenuate Cutaneous Sclerodermatous Graft-Versus-Host Disease (Scl-GVHD) through Inhibition of Immune Cell Infiltration in a Mouse Model

The Journal of Investigative Dermatology
Ji-Young LimChang-Ki Min

Abstract

Human chronic graft-versus-host disease (GVHD) shares clinical characteristics with a murine sclerodermatous GVHD model that is characterized by skin thickening and lung fibrosis. A B10.D2 → BALB/c transplant model of sclerodermatous GVHD was used to address the therapeutic effect of mesenchymal stem cells (MSCs) on the development of chronic GVHD. The clinical and pathological severity of cutaneous sclerodermatous GVHD was significantly attenuated in MSC-treated recipients relative to sclerodermatous GVHD control subjects. After MSC treatment, skin collagen production was significantly reduced, with consistent down-regulation of Tgfb expression. Effects of MSCs on molecular markers implicated in persistent transforming growth factor-β signaling and fibrosis, such as PTEN, phosphorylated Smad-2/3, and matrix metalloproteinase-1, were observed in skin tissue. MSCs neither migrate to the skin nor affect the in vivo expansion of immune effector cells, but they inhibited the infiltration of immune effector cells into skin via down-regulation of CCR4 and CCR8 expression on CD4+ T cells and CCR1 on CD11b+ monocyte/macrophages. MSCs diminished expression of chemokines such as CCL1, CCL3, CCL8, CCL17, and CCL22 in skin. MSCs were also ...Continue Reading

References

Apr 29, 1998·Nature·M Baggiolini
Jun 20, 2002·Archives of Dermatology·Pablo F PeñasAmaro García-Díez
Aug 1, 2002·Blood·Marco ZeccaUNKNOWN AIEOP-BMT Group. Italian Association for Pediatric Hematology and Oncology-Bone Marrow Transplant
Oct 3, 2002·Annual Review of Medicine·Georgia B VogelsangDebra M Bensen-Kennedy
Jul 4, 2003·The Journal of Clinical Investigation·Britt E AndersonWarren D Shlomchik
Dec 13, 2005·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Alexandra H FilipovichMary E D Flowers
May 30, 2006·Transplantation·Olle RingdénKatarina Le Blanc
Sep 12, 2006·The Journal of Biological Chemistry·Richard Seonghun NhoCraig A Henke
Feb 17, 2007·Acta Pharmacologica Sinica·Li GuXin-Lun Tian
Mar 3, 2007·The Journal of Clinical Investigation·John Varga, David Abraham
Jun 16, 2007·Proceedings of the National Academy of Sciences of the United States of America·Luis A OrtizDonald G Phinney
Dec 7, 2007·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Mayumi KusumotoToru Takeuchi
Mar 11, 2008·Rheumatic Diseases Clinics of North America·Jörg Distler, Oliver Distler
May 13, 2008·Lancet·Katarina Le BlancUNKNOWN Developmental Committee of the European Group for Blood and Marrow Transplantation
May 30, 2008·Frontiers in Bioscience : a Journal and Virtual Library·Minoru Hasegawa, Shinichi Sato
Mar 28, 2009·The European Respiratory Journal·M KumamotoK Matsushima
Jun 6, 2009·The American Journal of Pathology·Yuben MoodleyAlan Trounson
Sep 5, 2009·Current Opinion in Rheumatology·Emma C Derrett-SmithSonali Sonnylal
Dec 19, 2009·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Jeffery J AulettaWouter van't Hof
Feb 24, 2010·The Journal of Dermatology·Toshiyuki Yamamoto
Dec 31, 2010·Current Stem Cell Research & Therapy·Johanne M KaplanTracey A Lodie
Jan 14, 2011·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Edwin M HorwitzPartow Kebriaei
Apr 1, 2011·Expert Opinion on Biological Therapy·Jin WangJianming Tan
May 18, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Min-Hee OhTao Zheng
Sep 6, 2011·Stem Cell Reviews and Reports·Mohamed AbumareeBill Kalionis
Apr 1, 2014·Journal of Dermatological Science·Doanh Le HuuTakashi Matsushita

❮ Previous
Next ❯

Citations

Nov 11, 2019·Nature Reviews. Rheumatology·Yoshishige MiyabeAndrew D Luster
Sep 13, 2019·Cell Transplantation·Yu YouZuo-Jin Liu
Feb 6, 2018·Advanced Pharmaceutical Bulletin·Hamze TimariSara Aqmasheh
May 16, 2018·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Peiyi XieHong Shan
Jun 11, 2020·Cell & Bioscience·Benson KohMuhammad Dain Yazid
Feb 23, 2020·Stem Cells and Development·Masayoshi IshidaHiroshi Kaji
Jun 11, 2020·World Journal of Clinical Cases·Ya-Qun HongXiao-Fan Li
May 17, 2018·Stem Cells International·Yoojun NamJi Hyeon Ju
Apr 14, 2020·Cancer Cell International·Xinyi ZhouBaoan Chen
Jan 27, 2019·Journal of Pharmaceutical Investigation·Seok-Beom YongYong-Hee Kim
Oct 3, 2018·Frontiers in Immunology·Juliette PeltzerChristophe Martinaud
Jan 29, 2021·Stem Cells International·Yanyun LiJincheng Zeng
Mar 20, 2021·Stem Cell Research & Therapy·Alexander MarkovAli Hassanzadeh
Nov 19, 2021·Epigenomics·Liangliang ShenJingjun Zhao

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.